Monsanto to sales and distribution facilities in 51 countries. In 2005, it finalized the purchase of Seminis Inc, a leading global vegetable and fruit seed company, for $1.4 billion. This made it the world's largest conventional seed company. In 1999 Monsanto sold off NutraSweet Co. In December of the same year, Monsanto agreed to merge with Pharmacia & Upjohn, in a deal valuing the transaction at $27 billion. The agricultural division became a wholly owned subsidiary of the "new" Pharmacia; Monsanto's medical research division, which included products such as Celebrex. In 2000: Pharmacia spun off its agro-biotech subsidiary into a new
Monsanto legal cases this business model, companies invest heavily in research and development, and recoup the expenses through the use and enforcement of biological patents. In 1969, Monsanto sued Rohm and Haas for infringement of Monsanto's patent for the herbicide propanil. In Monsanto Co. v. Rohm and Haas Co., the Third Circuit Court of Appeals ruled against Monsanto on the basis that the company had fraudulently procured the patent it sought to enforce. Since the mid‑1990s, Monsanto indicates that it has filed suit against 145 individual U.S. farmers for patent infringement and/or breach of contract in connection with its genetically engineered seed but